NUVL FY 2024 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$280M

Net Income

-$261M

EPS (Diluted)

$-3.93

Cash Flow

Operating Cash Flow

-$185M

Free Cash Flow

-$185M

Stock-Based Comp.

$61M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$72M

Stockholders' Equity

$1.1B

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$280M	-$149M	-87.5%
Net Income	-$261M	-$126M	-106.6%